Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Effects of Chemoradiotherapy on Lymph Nodes in Patients with Rectal Adenocarcinoma: Evaluation of Numbers and Sizes of Retrieved Lymph Nodes Inside and Outside the Radiation Field

KAZUTAKE OKADA, SOTARO SADAHIRO, TOSHIYUKI SUZUKI, AKIRA TANAKA, GOTA SAITO, AKEMI KAMIJO, TAKESHI AKIBA and SHUICHI KAWADA
Anticancer Research August 2014, 34 (8) 4195-4200;
KAZUTAKE OKADA
1Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOTARO SADAHIRO
1Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sadahiro@is.icc.u-tokai.ac.jp
TOSHIYUKI SUZUKI
1Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIRA TANAKA
1Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GOTA SAITO
1Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKEMI KAMIJO
1Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI AKIBA
2Department of Radiology, Tokai University School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUICHI KAWADA
2Department of Radiology, Tokai University School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Preoperative chemoradiotherapy (CRT) decreases the number of retrieved lymph nodes (LNs) in rectal cancer. LNs inside the irradiation field are affected by CRT, whereas those outside the irradiation field are affected only by concurrent chemotherapy. Patients and Methods: The study cohort comprised of 210 patients with clinical stage II/III rectal adenocarcinoma. One hundred and eight received surgery alone (S group), and 102 received preoperative CRT (40 or 45 Gy) with concurrent oral UFT or S-1 uracil/tegafur or S-1 (CRT group). Results: The number of LNs inside the irradiation field was significantly smaller in the CRT group (4±4) than in the S group (6±6, p<0.01), but the number of LNs outside the irradiation field did not differ (5±4 in both groups). The longest diameters of LNs in the S group were significantly smaller than those of the CRT group both inside and outside the irradiation fields (p<0.01). Conclusion: The effects of CRT on LNs in patients with rectal adenocarcinoma differed inside and outside the radiation field.

  • Rectal cancer
  • chemoradiotherapy
  • radiotherapy
  • lymph nodes

In patients with colorectal cancer, retrieval of 12 or more lymph nodes (LNs) has been reported to be associated with better outcomes than retrieval of less than 12 LNs (1-3). Retrieval of at least 12 LNs has, therefore, been recommended to ensure reliable staging of disease (4, 5).

Preoperative radiotherapy or chemoradiotherapy (CRT) reduces local recurrence in patients with locally advanced adenocarcinoma of the rectum and is, therefore, used as standard treatment. Preoperative radiotherapy or CRT can reduce the number of retrieved LNs (6-11). Consequently, the recommended number of retrieved LNs remains unclear in patients with rectal adenocarcinoma who receive preoperative radiotherapy or CRT. LNs inside the irradiation field are affected by radiotherapy and concurrent chemotherapy, whereas LNs outside the irradiation field are affected only by concurrent chemotherapy. Therefore, we should evaluate the numbers of retrieved LNs inside and outside the radiation field separately if the effects of chemoradiotherapy on LNs differ between inside and outside the radiation field.

In the present study the number of retrieved LNs, the number of metastatic LNs, and sizes of LNs inside and outside the radiation field were compared between patients with rectal adenocarcinoma who underwent surgery alone and those who received CRT before surgery.

Patients and methods

Patients. The study group comprised of 108 patients with pathological stage II or III adenocarcinoma of the middle or lower rectum who received radical surgery alone (S group) and 102 patients with a preoperative diagnosis of clinical stage II or III adenocarcinoma of the middle or lower rectum who underwent radical surgery after CRT (CRT group) at Tokai University Hospital from January 1991 through December 2010. The initial evaluation included digital examination of the rectum, chest x-ray, colonoscopy, barium enema as well as computed tomography of the abdomen and pelvis. Endorectal ultrasonography and magnetic resonance imaging of the pelvis was also performed since 1994.

In Japan, both radical surgery with lateral lymph-node dissection (12) and preoperative CRT plus mesorectal excision are currently used to treat locally advanced rectal adenocarcinoma. Therefore, during the study period, patients selected therapy after receiving a detailed explanation of each treatment from their physicians.

This study was approved by the institutional review board of our university (08R-032).

CRT and surgery. Preoperative radiotherapy was performed with 18 MeV X-ray beams delivered by a linear accelerator (Clinac 2100C, Varian Medical Systems, Inc., Palo Alto, CA, USA), using a four-field technique. Irradiation was performed once (1.8 or 2.0 Gy) daily to a total dose of 40 or 45 Gy. The superior border of the radiation field was the lumbosacral L5/S1 junction, and the lateral borders were 1 cm lateral to the widest bony margin of the true pelvic sidewalls. The inferior border was at the level of the inferior edges of the obturator foramen or 3 cm below the site of the tumor. The field size ranged from 15×15 cm to 16×18 cm. Surgery was done 6 to 8 weeks (range 30 to 65 days) after the completion of radiotherapy. For concomitant chemotherapy, 21 patients received oral uracil/tegafur (UFT, 400 mg/m2 Taiho Pharmaceutical CO., LTD. Tokyo, Japan) and 81 received oral S-1 (80 mg/m2 Taiho Pharmaceutical CO., LTD. Tokyo, Japan), starting at the same time as radiotherapy. Oral UFT was given for 5 days, followed by a 2-day rest. This cycle was repeated. Oral S-1 (80 mg/m2) was given for 2 consecutive weeks, followed by a 1-week rest, and was then given for 2 more weeks (13).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Definition of lymph node distribution.

All patients underwent mesorectal excision. The inferior mesenteric artery was ligated at its aortic origin in all patients. In patients in the S group, lateral lymph-node dissection was routinely performed; however, the lateral LNs were not evaluated in the present study.

In Japan, LNs along the inferior mesenteric artery have conventionally been divided into 3 groups: peri-rectal LNs, intermediate LNs, and main LNs. The border between the perirectal LNs and the intermediate LNs is the origin of the terminal sigmoid artery (Figure 1) (14).

Pathology procedures. One of the members of the colorectal surgical team dissected the resected specimen in the operation room within 30 min after excision. LNs were identified by direct inspection and manual palpation after closely slicing the mesorectum and sigmoid mesentery. Fat clearance methods were not used in any of the cases. In Japan, surgeons dissect the surgical specimen and identify LNs. Pathologists examine all specimens considered to be LNs.

Evaluation of the numbers and sizes of the retrieved LNs. The numbers of retrieved LNs and metastatic LNs were obtained by reviewing the patients' pathological charts. The sizes of LNs (longest axis, shortest axis, and area) were measured on specimens stained with hematoxylin and eosin, using a computer digitizer (Adobe Photoshop CS5®, Adobe Systems, San Jose, California, USA).

Definition of lymph node regions. The superior border of the radiation field is the L5/S1 junction. Because the mesorectum was not marked at the level of the promontory during surgery, it was difficult to accurately determine the radiation field on resected specimens. LNs along the inferior mesenteric artery were divided into two groups at the origin of the terminal sigmoid artery according to the Japanese criteria (14): (i) the perirectal LNs and (ii) the intermediate LNs and main LNs. In the present study, the perirectal LNs were defined as being inside the radiation field while the intermediate LNs and the main LNs were defined as being outside the radiation field.

LNs in other locations, such as lateral LNs and LNs in the sigmoid mesentery, were defined as LNs in the border field and were not evaluated in the present study.

Statistical analyses. The Student's t-test was used to compare continuous variables such as the numbers and sizes of LNs. The Pearson's chi-square test was used to compare discrete variables.

Results

Patients' characteristics. The distance from the anal verge to the tumor was significantly shorter in the CRT group than in the S group. The CRT group comprised significantly lower proportions of patients with lymphatic and venous invasion. After preoperative CRT, tumor downstaging was noted in 40 (39%) patients in the CRT group. All patients' characteristics are shown in Table I.

Numbers of LNs evaluated. The total number of retrieved LNs evaluated was 1,160 in the S group and 892 in the CRT group. The total number of metastatic LNs was 118 in the S group and 107 in the CRT group.

Numbers of retrieved LNs. The total number of retrieved LNs was significantly lower in the CRT group than in the S group (p<0.01). The number of retrieved LNs inside the irradiation field was significantly lower in the CRT group than in the S group (p<0.01). The numbers of retrieved LNs outside the irradiation field did not differ significantly between the groups (Table II).

Forty-four patients with stage II disease in the S group were compared against 75 patients without positive LNs in the CRT group. The total number of retrieved LNs was significantly lower in the CRT group than in the S group (p<0.01). The number of retrieved LNs inside the irradiation field was significantly lower in the CRT group than in the S group (p<0.01). The number of retrieved LNs outside the irradiation field was also significantly lower in the CRT group than in the S group (p<0.01). Sixty-four patients with stage III disease in the S group were compared against 27 patients with stage III disease in the CRT group. The total number of retrieved LNs was significantly greater in the CRT group than in the S group (p=0.03).

Numbers of LNs in patients with Stage III disease. The number of metastatic LNs was significantly greater in the CRT group than in the S group within the irradiation field (p<0.01). Outside the irradiation field, there was no significant difference in the numbers of metastatic LNs. The numbers of negative LNs did not differ significantly between the two groups (Table III).

Sizes of negative LNs. Negative LNs inside the irradiation field as well as those outside the irradiation field were significantly smaller in the CRT group than in the S group (p<0.01) (Table IV). Similar results were obtained regardless of whether size was evaluated on the basis of longest diameter, shortest diameter, or area. In patients without positive LNs, LNs inside the irradiation field as well as those outside the irradiation field were significantly smaller in the CRT group than in the S group (p<0.01). However, in patients with stage III disease, the sizes of negative LNs, either inside or outside the radiation field, did not differ significantly between the CRT group and the S group.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Patients' characteristics.

Sizes of metastatic LNs in patients with Stage III disease. The sizes of positive LNs inside as well as outside the radiation field were significantly smaller in the CRT group than in the S group (Table V).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Numbers of retrieved lymph nodes.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Numbers of lymph nodes in patients with Stage III disease.

Discussion

Several studies have shown that local disease control is significantly better after CRT including preoperative long-term, low-dose conventional irradiation than after radiotherapy alone (15, 16). We concurrently used oral UFT or S-1 as a radiosensitizer. Radiation most likely affects LNs inside the irradiation field, whereas chemotherapy is considered to also have an impact on LNs outside the irradiation field.

Pan et al. reported good outcomes after surgery-alone in patients with rectal cancer in whom at least 12 LNs were retrieved, whereas in patients who received CRT the best outcomes were associated with 7 to 11 retrieved LNs (17). Tsai et al. found that patients with more than 7 retrieved LNs showed better outcomes than those with 7 or fewer retrieved LNs (18). Since the number of retrieved LNs decreases in patients who receive CRT (6-11), the recommended number of retrieved LNs remains unclear (18).

Within the irradiation field, the numbers and sizes of retrieved LNs were significantly smaller in the CRT group than in the S group. These findings were attributed to the effects of CRT. Outside the radiation field, the numbers of retrieved LNs did not differ significantly between the two groups, but LNs were significantly smaller in the CRT group than in the S group. These findings were most likely caused by the effects of concurrent chemotherapy.

The abscopal effect is a rare phenomenon in which radiotherapy causes the regression of metastatic cancer at a distance from the irradiated site. Cell-mediated immunity is thought to be involved (19, 20). Shrinkage of LNs outside the radiation field may principally be attributed to the effects of concurrent chemotherapy, but to other factors as well, including abscopal effects.

In the subgroup of patients without positive LNs, the numbers and sizes of retrieved LNs were significantly smaller in the CRT group than in the surgery group both inside and outside the radiation field (Tables II and IV). On the contrary, there were significantly increased numbers of retrieved LNs and of metastatic LNs in the CRT group in patients with Stage III disease.

Preoperative radiotherapy or CRT reduced the number of retrieved LNs (6-11). However, the results of the number of metastatic LNs were various. Govindarajan et al. and Rullier et al. reported that CRT reduced the number of metastatic LNs (10, 11). Marijnen et al. reported no change (6) while Fuente et al. also reported that the number of metastatic LNs was significantly greater in patients who received CRT than in those who underwent surgery-alone (8). These discrepancies, however, remain unspecified.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Sizes of negative lymph nodes.

Lymph node cells die rapidly at inter-phase after exposure to low-dose radiation (21). Lymphocytes die without undergoing cell division within hours after irradiation, whereas tumor-cell death requires more time (6). In vitro, 2 to 5 rads of radiation is cytotoxic to lymphocytes (22), whereas the mean lethal dose against colonic carcinoma is 94 rads (23). Colon cancer cells are thus more radioresistant than lymphocytes. Therefore, the impact of CRT may differ substantially between normal tissue and metastatic cancer tissue in LNs.

The size of LNs following formalin fixation has been reported decrease by 52.8% for the longest diameter and 61.8% for the shortest diameter when they are compare to the original dimensions measured during surgery. (24). Therefore, our estimates are probably equivalent to less than one half of actual size in vivo.

Our results showed that the response of LNs to CRT differed between inside and outside of the radiation field. Effects of concurrent chemotherapy with UFT or S-1 were evident outside the radiation field. Our results suggested the that in some patients their initial metastatic LNs, become negative and are downstaged while negative LNs shrink further in patients who are more sensitive to CRT. Also, in patients who are less sensitive to CRT, positive LNs shrink, but metastases remain while the reduction in the size of negative LNs is less. Therefore, the relation of oncologic outcomes to the number of retrieved LNs and the size of negative LNs should be separately evaluated inside and outside the irradiation field in patients with rectal cancer who receive CRT.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table V.

Sizes of metastatic lymph nodes in patients with Stage III disease.

Conclusion

The effects of chemoradiotherapy on LNs in patients with rectal adenocarcinoma differed inside and outside the radiation field. LNs should be separately evaluated inside and outside the irradiation field in studies assessing the relations between the numbers of LNs and oncological outcomes.

Footnotes

  • This article is freely accessible online.

  • Conflicts of Interest

    The Authors indicated no potential conflicts of interest. None of the Authors received any funding support for this work.

  • Received April 15, 2014.
  • Revision received May 31, 2014.
  • Accepted June 2, 2014.
  • Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Goldstein NS
    : Lymph node recoveries from 2427 pt3 colorectal resection specimens spanning 45 years: Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26: 179-189, 2002.
    OpenUrlCrossRefPubMed
    1. Le Voyer TE,
    2. Sigurdson ER,
    3. Hanlon AL,
    4. Mayer RJ,
    5. Macdonald JS,
    6. Catalano PJ,
    7. Haller DG
    : Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089. J Clin Oncol 21: 2912-2919, 2003.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. George S,
    2. Primrose J,
    3. Talbot R,
    4. Smith J,
    5. Mullee M,
    6. Bailey D,
    7. du Boulay C,
    8. Jordan H
    : Will rogers revisited: Prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer 95: 841-847, 2006.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Vather R,
    2. Sammour T,
    3. Zargar-Shoshtari K,
    4. Metcalf P,
    5. Connolly A,
    6. Hill A
    : Lymph node examination as a predictor of long-term outcome in dukes b colon cancer. Int J Colorectal Dis 24: 283-288, 2009.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Lee S,
    2. Hofmann LJ,
    3. Davis KG,
    4. Waddell BE
    : Lymph node evaluation of colon cancer and its association with improved staging and survival in the department of defense health care system. Ann Surg Oncol 16: 3080-3086, 2009.
    OpenUrlPubMed
  5. ↵
    1. Marijnen CA,
    2. Nagtegaal ID,
    3. Klein Kranenbarg E,
    4. Hermans J,
    5. van de Velde CJ,
    6. Leer JW,
    7. van Krieken JH
    : No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19: 1976-1984, 2001.
    OpenUrlAbstract/FREE Full Text
    1. Wichmann MW,
    2. Muller C,
    3. Meyer G,
    4. Strauss T,
    5. Hornung HM,
    6. Lau-Werner U,
    7. Angele MK,
    8. Schildberg FW
    : Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 137: 206-210, 2002.
    OpenUrlCrossRefPubMed
  6. ↵
    1. de la Fuente SG,
    2. Manson RJ,
    3. Ludwig KA,
    4. Mantyh CR
    : Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. J Gastrointest Surg 13: 269-274, 2009.
    OpenUrlCrossRefPubMed
    1. Ha YH,
    2. Jeong SY,
    3. Lim SB,
    4. Choi HS,
    5. Hong YS,
    6. Chang HJ,
    7. Kim DY,
    8. Jung KH,
    9. Park JG
    : Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg 252: 336-340, 2010.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Govindarajan A,
    2. Gonen M,
    3. Weiser MR,
    4. Shia J,
    5. Temple LK,
    6. Guillem JG,
    7. Paty PB,
    8. Nash GM
    : Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol 29: 4568-4573, 2011.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Rullier A,
    2. Laurent C,
    3. Capdepont M,
    4. Vendrely V,
    5. Belleannee G,
    6. Bioulac-Sage P,
    7. Rullier E
    : Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: Number, status, and impact on survival. Am J Surg Pathol 32: 45-50, 2008.
    OpenUrlPubMed
  9. ↵
    1. Fujita S,
    2. Akasu T,
    3. Mizusawa J,
    4. Saito N,
    5. Kinugasa Y,
    6. Kanemitsu Y,
    7. Ohue M,
    8. Fujii S,
    9. Shiozawa M,
    10. Yamaguchi T,
    11. Moriya Y
    : Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (jcog0212): Results from a multicentre, randomised controlled, non-inferiority trial. The lancet oncology 13: 616-621, 2012.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Sadahiro S,
    2. Suzuki T,
    3. Tanaka A,
    4. Okada K,
    5. Kamijo A,
    6. Murayama C,
    7. Akiba T,
    8. Nakayama Y
    : Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma. Oncology 81: 306-311, 2011.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Japanese Society for Cancer of the Colon and Rectum
    . Japanese Classification of Colorectal Carcinoma. 2nd English edition. Kanehara & Co, Ltd, Tokyo 2009.
  12. ↵
    1. Bosset JF,
    2. Collette L,
    3. Calais G,
    4. Mineur L,
    5. Maingon P,
    6. Radosevic-Jelic L,
    7. Daban A,
    8. Bardet E,
    9. Beny A,
    10. Ollier JC
    : Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355: 1114-1123, 2006.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Gerard JP,
    2. Conroy T,
    3. Bonnetain F,
    4. Bouche O,
    5. Chapet O,
    6. Closon-Dejardin MT,
    7. Untereiner M,
    8. Leduc B,
    9. Francois E,
    10. Maurel J,
    11. Seitz JF,
    12. Buecher B,
    13. Mackiewicz R,
    14. Ducreux M,
    15. Bedenne L
    : Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of ffcd 9203. J Clin Oncol 24: 4620-4625, 2006.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Pan CJ,
    2. Ziogas A,
    3. Buchberg B,
    4. Raj KP,
    5. Mills SD,
    6. Stamos MJ,
    7. Zell JA
    : Timing of radiation therapy, lymph node retrieval, and survival in rectal cancer. Dis Colon Rectum 54: 526-534, 2011.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Tsai CJ,
    2. Crane CH,
    3. Skibber JM,
    4. Rodriguez-Bigas MA,
    5. Chang GJ,
    6. Feig BW,
    7. Eng C,
    8. Krishnan S,
    9. Maru DM,
    10. Das P
    : Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117: 3713-3722, 2011.
    OpenUrlPubMed
  16. ↵
    1. Kaminski JM,
    2. Shinohara E,
    3. Summers JB,
    4. Niermann KJ,
    5. Morimoto A,
    6. Brousal J
    : The controversial abscopal effect. Cancer Treat Rev 31: 159-172, 2005.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Postow MA,
    2. Callahan MK,
    3. Barker CA,
    4. Yamada Y,
    5. Yuan J,
    6. Kitano S,
    7. Mu Z,
    8. Rasalan T,
    9. Adamow M,
    10. Ritter E,
    11. Sedrak C,
    12. Jungbluth AA,
    13. Chua R,
    14. Yang AS,
    15. Roman RA,
    16. Rosner S,
    17. Benson B,
    18. Allison JP,
    19. Lesokhin AM,
    20. Gnjatic S,
    21. Wolchok JD
    : Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366: 925-931, 2012.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Lowenthal JW,
    2. Harris AW
    : Activation of mouse lymphocytes inhibits induction of rapid cell death by x-irradiation. J Immunol 135: 1119-1125, 1985.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Stefani S,
    2. Schrek R
    : Cytotoxic effect of 2 and 5 roentgens on human lymphocytes irradiated in vitro. Radiat Res 22: 126-129, 1964.
    OpenUrlPubMed
  20. ↵
    1. Smith IE,
    2. Courtenay VD,
    3. Mills J,
    4. Peckham MJ
    : In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res 38: 390-392, 1978.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Ishida H,
    2. Hatano S,
    3. Ishiguro T,
    4. Kumamoto K,
    5. Ishibashi K,
    6. Haga N
    : Prediction of lateral lymph node metastasis in lower rectal cancer: Analysis of paraffin-embedded sections. Jpn J Clin Oncol 42: 485-490, 2012.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Anticancer Research: 34 (8)
Anticancer Research
Vol. 34, Issue 8
August 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Chemoradiotherapy on Lymph Nodes in Patients with Rectal Adenocarcinoma: Evaluation of Numbers and Sizes of Retrieved Lymph Nodes Inside and Outside the Radiation Field
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Effects of Chemoradiotherapy on Lymph Nodes in Patients with Rectal Adenocarcinoma: Evaluation of Numbers and Sizes of Retrieved Lymph Nodes Inside and Outside the Radiation Field
KAZUTAKE OKADA, SOTARO SADAHIRO, TOSHIYUKI SUZUKI, AKIRA TANAKA, GOTA SAITO, AKEMI KAMIJO, TAKESHI AKIBA, SHUICHI KAWADA
Anticancer Research Aug 2014, 34 (8) 4195-4200;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Effects of Chemoradiotherapy on Lymph Nodes in Patients with Rectal Adenocarcinoma: Evaluation of Numbers and Sizes of Retrieved Lymph Nodes Inside and Outside the Radiation Field
KAZUTAKE OKADA, SOTARO SADAHIRO, TOSHIYUKI SUZUKI, AKIRA TANAKA, GOTA SAITO, AKEMI KAMIJO, TAKESHI AKIBA, SHUICHI KAWADA
Anticancer Research Aug 2014, 34 (8) 4195-4200;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival
  • Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy
  • Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib
Show more Clinical Studies

Similar Articles

Keywords

  • Rectal cancer
  • chemoradiotherapy
  • radiotherapy
  • lymph nodes
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire